News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
566,828 Results
Type
Article (45345)
Company Profile (97)
Press Release (521386)
Section
Business (159850)
Career Advice (2470)
Deals (28848)
Drug Delivery (86)
Drug Development (74834)
Employer Resources (149)
FDA (13973)
Job Trends (12786)
News (283226)
Policy (28082)
Tag
Academia (2761)
Alliances (41518)
Alzheimer's disease (1264)
Approvals (13890)
Artificial intelligence (115)
Bankruptcy (317)
Best Places to Work (10264)
Breast cancer (111)
Cancer (925)
Cardiovascular disease (87)
Career advice (2079)
Cell therapy (201)
Clinical research (59044)
Collaboration (307)
Compensation (95)
COVID-19 (2534)
C-suite (90)
Data (871)
Diabetes (129)
Diagnostics (5720)
Drug pricing (75)
Earnings (54224)
Employer resources (137)
Events (77533)
Executive appointments (255)
FDA (14403)
Funding (281)
Gene therapy (154)
GLP-1 (553)
Government (4277)
Healthcare (16958)
Infectious disease (2614)
Inflammatory bowel disease (99)
Interviews (521)
IPO (12859)
Job creations (2794)
Job search strategy (1718)
Layoffs (374)
Legal (6009)
Lung cancer (158)
Manufacturing (142)
Medical device (11069)
Medtech (11073)
Mergers & acquisitions (16006)
Metabolic disorders (357)
Neuroscience (1514)
NextGen Class of 2024 (5920)
Non-profit (4389)
Northern California (1091)
Obesity (203)
Opinion (198)
Patents (93)
People (51999)
Phase I (18201)
Phase II (25985)
Phase III (19691)
Pipeline (247)
Postmarket research (2394)
Preclinical (7627)
Radiopharmaceuticals (216)
Rare diseases (186)
Real estate (4646)
Regulatory (18975)
Research institute (2457)
Resumes & cover letters (360)
Southern California (992)
Startups (3024)
United States (10234)
Vaccines (530)
Weight loss (158)
Date
Today (184)
Last 7 days (790)
Last 30 days (2807)
Last 365 days (31968)
2024 (27655)
2023 (35478)
2022 (46015)
2021 (49692)
2020 (48545)
2019 (42365)
2018 (32026)
2017 (28506)
2016 (27339)
2015 (31864)
2014 (24145)
2013 (20011)
2012 (21466)
2011 (22313)
2010 (19896)
Location
Africa (777)
Arizona (120)
Asia (34962)
Australia (7263)
California (2413)
Canada (1083)
China (197)
Colorado (108)
Connecticut (102)
Europe (79009)
Florida (364)
Georgia (84)
Illinois (285)
Indiana (173)
Kansas (86)
Maryland (486)
Massachusetts (1830)
Michigan (129)
Minnesota (205)
New Jersey (750)
New York (767)
North Carolina (584)
Northern California (1091)
Ohio (114)
Pennsylvania (641)
South America (1056)
Southern California (992)
Texas (340)
Utah (79)
Washington State (284)
566,828 Results for "wellcome trust sanger institute formerly known as sanger centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rejuvenate Biomed, the NIHR Leicester BRC, and Wellcome Leap partner for Phase 2 Study in COPD-related sarcopenia
October 28, 2024
·
5 min read
Genetown
Wellcome Sanger Institute Adopts Genestack’s Omics Data Manager for Human Genetics Datasets
Genestack Ltd. announced that its flagship multi-omics data catalog, curation and integrative search product, Omics Data Manager, has been licensed and implemented by a world-leading genomics research centre, the Wellcome Sanger Institute.
April 22, 2021
·
3 min read
Sanger Sequencing Services Market Trend | Increasing Application of Sanger Sequencing in Molecular Biology Techniques and Rising Funding to Accelerate Genomics and Molecular Biology Research Activities
The Sanger Sequencing Services Market is expected to grow at a CAGR of 6.5% during the forecast period , according to latest analysis by Emergen Research.
September 13, 2022
·
6 min read
Bio NC
Atrium Health’s Sanger Heart & Vascular Institute First in the World to use Implantable Fish-Skin Grafting in Reconstructive Surgery
Atrium Health’s Sanger Heart & Vascular Institute has received a Center of Excellence designation from Kerecis®, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection.
July 6, 2022
·
5 min read
Sanger Sequencing Services Market Size to Reach USD 3.4 billion by 2027 | Emergen Research
The global sanger sequencing services market was valued at USD 1.6 billion in 2019 and is expected to reach USD 3.4 billion by 2027, growing at a CAGR of 10.1% from 2020 to 2027, according to latest study by Emergen Research.
September 22, 2022
·
7 min read
Business
Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC
Arima Genomics, Inc., a biotechnology company accelerating the adoption of the genome structure information, announced today that its new high-coverage HiC technology has been evaluated and implemented at the Wellcome Sanger Institute for projects, including the Darwin Tree of Life project, in an effort to explore the true genetic diversity between species and between individuals within a species. The Wellcome Sanger Insti
October 5, 2020
·
5 min read
Sanger Sequencing Services Market Trend | Growing Awareness About Advantages of Sanger Sequencing and Rising Investments in Effective Drug Delivery are Some Key Factors Expected to Drive Global Market Growth
Sanger sequencing is one of the oldest DNA sequencing methods carried out using oligonucleotide primers and chain termination.
April 22, 2022
·
7 min read
Press Releases
KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust
November 5, 2024
·
6 min read
Genetown
Stealth BioTherapeutics Presents Data of Novel Compound, SBT-589, in Friedreich’s Ataxia Cardiac Models at the Wellcome Trust Mitochondrial Medicine Conference
Stealth BioTherapeutics Inc. announced today the presentation of new SBT-589 data demonstrating cardioprotective effects across pre-clinical models of Friedreich’s ataxia (FA).
March 19, 2024
·
3 min read
Business
Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that the Wellcome Sanger Institute has committed to purchase seven new Sequel IIe Systems and upgrade its five existing Sequel II Systems to increase its long-read sequencing capabilities for projects including the Darwin Tree of Life (DToL; all eukaryotes in Britain and Ireland) and Aquatic Symbiosis G
January 8, 2021
·
6 min read
1 of 56,683
Next
